Meperidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Meperidine Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 05/30/2025. Reported reason: Discontinuation of the manufacture of the drug
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-1362-01
- Dosage Form
- Injection
- Presentation
- Demerol, Injection, 25 mg/1 mL (NDC 0409-1362-01)
- Initial Posting
- 05/30/2025
- Revised Date
Reason
Discontinuation of the manufacture of the drug